drugset / Trial / NCT02380508

Heterologous Effects of BCG in Healthy UK Adults

NCT02380508

Completed 36 enrolled University of Oxford
RandomizedParallel-groupOpen-label

Summary

TB038 is a clinical study to assess the non-specific effects of BCG vaccination and gain a better understanding of how the body's immune system reacts to BCG and in turn potentially prevents infection from other bacteria.

Timeline

Start
2015-02
Primary completion
2016-11
Completion
2016-11

Drugs

EvaluationDrugModalityDoseRoute
Subject BCG SII Vaccine Other
Subject BCG SSI Vaccine Other

Indications